Evidence map›Paper›PMID 33505127›Full record

ArticleIndian journal of clinical biochemistry : IJCB2021

Jigna Joshi, Apexa Raval, Urja Desai, Vinal Upadhyay, Mansi Bhavsar, Kanisha Shah, Rakesh Rawal, Harsha Panchal, Franky Shah

Open access · greenAbstract read
In one paragraph

Article in Indian journal of clinical biochemistry : IJCB, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Liquid Biopsy: The Challenges of a Revolutionary Approach in Oncology.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jigna JoshiStem Cell Biology Lab, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat India.
Apexa RavalStem Cell Biology Lab, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat India.
Urja DesaiStem Cell Biology Lab, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat India.
Vinal UpadhyayMedicinal Chemistry and Pharmacogenomics Division, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, India.
Mansi BhavsarMedicinal Chemistry and Pharmacogenomics Division, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, India.
Kanisha ShahMedicinal Chemistry and Pharmacogenomics Division, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, India.
Rakesh RawalMedicinal Chemistry and Pharmacogenomics Division, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, India.
Harsha PanchalMedical Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, India.
Franky ShahStem Cell Biology Lab, Department of Cancer Biology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat India.ORCID 0000-0002-7265-2839
Gujarat Cancer & Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the era of the targeted therapy identification of

Indexed as

ARMS real-time PCRCell-free DNAEGFR mutationNon-small cell lung cancer

Identifiers

PMID33505127
PMCPMC7817738
OpenAlexW2993423899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.